secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001558370-24-015884
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Dogwood Therapeutics receives Nasdaq delisting notice for low stockholders' equity
--------------------------------------------------------------------------------

- Stockholders' equity fell below $2.5M minimum per Q3 2024 10-Q; delisting risk under Nasdaq Rule 5550(b)(1).
- Company has until December 30, 2024 to submit a compliance plan; Nasdaq may grant up to 180-day extension.
- Acquisition of Pharmagesic closed Oct 7, 2024, after the Q3 report, not reflected in equity calculation.
- No immediate effect on listing; common stock (DWTX) continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024015884/0001558370-24-015884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024015884/dwtx-20241115x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-015884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer